SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001419
Filing Date
2024-01-16
Accepted
2024-01-16 17:18:45
Documents
18
Period of Report
2024-01-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240116_8k.htm   iXBRL 8-K 33135
2 EXHIBIT 5.1 ex_615538.htm EX-5.1 7665
3 EXHIBIT 10.1 ex_615503.htm EX-10.1 127025
4 EXHIBIT 99.1 ex_615633.htm EX-99.1 13926
9 z01.jpg GRAPHIC 12774
10 z02.jpg GRAPHIC 11862
  Complete submission text file 0001437749-24-001419.txt   387240

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240116.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240116_def.xml EX-101.DEF 11424
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240116_lab.xml EX-101.LAB 15310
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240116_pre.xml EX-101.PRE 11584
12 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240116_8k_htm.xml XML 2556
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 24536027
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)